845 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·myChoice CDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP142) Assay
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·COBAS EGFR MUTATION TEST V2
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·TruSight Oncology Comprehensive
Prosthesis, Hip, Hemi-, Trunnion-Bearing, Femoral, Metal/Polyacetal
FDA classification
FDA Class 3
·Prosthesis, Hip, Hemi-, Trunnion-Bearing, Femoral, Metal/Polyacetal
Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)
Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component)
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component)
Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic, Cemented
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic, Cemented
Prosthesis, Hip, Semi-Constrained, Ceramic-On-Metal Articulation
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained, Ceramic-On-Metal Articulation
Immunohistochemistry Antibody Assay, C-Kit
FDA Pre-Market Approval
FDA Class 3
·VENTANA MEDICAL SYSTEMS PATHWAY ANTI-C-KIT (9.7) PRIMARY ANTIBODY
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·xT CDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) ASSAY
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·THERASCEEN EGFR RGQ PCR KIT
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY Anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·ONCO/Reveal Dx Lung & Colon Cancer Assay (O/RDx-LCCA)
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA classification
FDA Class 3
·Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY ANTI-HER-2/NEU (4B5) PRIMARY ANTIBODY
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) CDX ASSAY
Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented